FDA nod to new MS drug spells trouble for Teva

Published June 13, 2010

FDA nod to new MS drug spells trouble for Teva
Novartis AG’s experimental multiple sclerosis pill moved one step closer to winning U.S. approval on Thursday when a Food and Drug Administration advisory panel backed the drug to help reduce and delay patients’ symptoms.